Document is current
Any future updates will be listed below
-
Authors
Pierce, Sarah E.
Erwood, Steven
Oye, Keyede
An, Meirui https://orcid.org/0000-0002-4006-8670
Krasnow, Nicholas https://orcid.org/0000-0002-4131-1855
Zhang, Emily https://orcid.org/0000-0002-9053-1336
Raguram, Aditya https://orcid.org/0000-0002-5749-7308
Seelig, Davis
Osborn, Mark J.
Liu, David R. https://orcid.org/0000-0002-9943-7557
- License Information
-
More Information
Article History
Received: 2 March 2025
Accepted: 9 October 2025
First Online: 19 November 2025
Change Date: 6 January 2026
Change Type: Update
Change Details: The authors were alerted of errors in the pathology report included in the Supplementary Information for this paper. After reviewing all the information and records, we confirm that the mouse identification numbers were incorrectly listed in the narrative text of the pathology report, and the study title on the signature page of the pathology report was also incorrectly listed. The authors have corrected these errors in an updated pathology report, which also includes clarification of the timing for unblinding. The mouse and pathology IDs were correct in the data tables, and the conclusions are not affected.
Competing interests
: S.E.P., S.E., K.O., A.R. and D.R.L. are inventors on a patent application filed by the Broad Institute on the design and applications of PERT. D.R.L. is a co-founder of Beam Therapeutics, Prime Medicine, Pairwise Plants, Editas Medicine and nChroma Bio, companies that use or deliver genome-editing agents. The other authors declare no competing interests.
